Need professional-grade analysis? Visit stockanalysis.com
$725.37M
N/A
166
N/A
Compass Pathways Plc (CMPS) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at $9.25, up 38.89% from the previous close.
Over the past year, CMPS has traded between a low of $2.35 and a high of $9.25. The stock has gained 159.1% over this period. It is currently 293.6% above its 52-week low.
Compass Pathways Plc has a market capitalization of $725.37M.
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Side-by-side comparison against top Healthcare peers.